Headline News

 

Litifilimab receives FDA breakthrough therapy designation for Cutaneous Lupus Erythematosus

Posted on February 03, 2026

AbbVie’s Love in Mind set to spotlight the emotional impact of Migraines

Posted on February 03, 2026

Novo Nordisk’s CagriSema demonstrated superior HbA1c reduction and weight loss in adults with type 2 diabetes in the REIMAGINE 2 trial

Posted on February 03, 2026

Sanofi’s venglustat succesfully met all primary endpoints in a phase 3 study of type 3 Gaucher disease

Posted on February 03, 2026

Rezurock recommended for EU approval to treat chronic graft-vs-host disease

Posted on February 03, 2026

AstraZeneca expands through collaboration agreement with CSPC Pharmaceuticals

Posted on February 03, 2026

AstraZeneca’s Imfinzi perioperative regimen recommended for approval for patients with early gastric and gastroesophageal cancers

Posted on February 03, 2026

Update on Saphnelo subcutaneous administration in systemic lupus erythematosus

Posted on February 03, 2026

AstraZeneca’s Datroway granted Priority Review for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy

Posted on February 03, 2026

Lilly’s newest injectable medicine and device manufacturing facility in Pennsylvania

Posted on February 03, 2026

Aspect Biosystems and Novo Nordisk enter partnership to develop diabetes medicines

Posted on January 27, 2026

LEQEMBI IQLIK accepted as a SBLA as a subcutaneous starting dose for the treatment of early alzheimer’s disease under priority review

Posted on January 27, 2026

Abbott receives CE mark for the TactiFlex duo ablation catheter for the treatment of patients with abnormal heart rhythms

Posted on January 27, 2026

Abbott’s neuromodulation systems reduce healthcare visits due to pain And deliver sustained relief

Posted on January 27, 2026

GSK set to acquire RAPT Therapeutics

Posted on January 27, 2026